文献速递儿童神经与发育行为儿童内分泌与遗传代谢

55例儿童线粒体呼吸链复合酶联合缺陷的临床表现、遗传病因与辅酶Q10水平

Clinical Presentation, Genetic Etiology, and Coenzyme Q10 Levels in 55 Children with Combined Enzyme Deficiencies of the Mitochondrial Respiratory Chain.
PubMed 文献 · J Pediatr · 2020-08-19

该研究收集55例线粒体呼吸链复合酶联合缺陷患儿的临床与生化数据,并行线粒体基因组测序,其中32例接受WES/WGS。疾病中位起病年龄6周,常见肌无力、肌张力低下和发育迟缓/智力障碍,非神经系统症状频繁。在20个不同核基因及7例线粒体DNA中发现致病突变,WES/WGS在32例中检出18例;55例中35例(64%)建立遗传诊断。许多患者肌肉辅酶Q10水平低,与遗传病因无关。

要点

  • 线粒体呼吸链复合酶联合缺陷患儿常早期起病,以肌无力、肌张力低下和发育迟缓/智力障碍为常见表现。
  • 非神经系统症状频繁出现,遗传病因涉及多个核基因及线粒体DNA突变。
  • WES/WGS提高诊断率,55例中35例(64%)建立遗传诊断;肌肉辅酶Q10低水平与遗传病因无关。

核心结论

  • 儿童线粒体呼吸链复合酶联合缺陷临床表现多样且起病年龄不一,通过大规模平行测序可在55例中35例(64%)建立遗传诊断。

研究设计与样本

  • 研究收集55例线粒体呼吸链复合酶联合缺陷患儿的临床和生化数据,对所有患者行整个线粒体基因组序列分析(除非已根据临床表现确定致病突变),并对32例患者行WES/WGS。

主要发现

  • 疾病中位起病年龄为6周,最常见症状为肌无力、肌张力低下和发育迟缓/智力障碍,非神经系统症状频繁。
  • 在20个不同核基因中发现致病突变,7例患者有线粒体DNA突变。
  • 32例接受WES/WGS的患者中18例发现致病变异。
  • 许多患者肌肉辅酶Q10水平低,与遗传病因无关。

关键数值与推荐

  • 55例中35例(64%)建立遗传诊断。
  • 疾病中位起病年龄6周。
  • 致病突变涉及20个不同核基因,7例有线粒体DNA突变。
  • WES/WGS在32例中检出18例致病变异。

临床怎么用

  • 对疑似线粒体呼吸链复合酶联合缺陷的儿童,应关注早期起病的肌无力、肌张力低下和发育迟缓/智力障碍,并注意非神经系统症状。
  • 可考虑线粒体基因组测序及WES/WGS以明确遗传病因,提高诊断率。
  • 肌肉辅酶Q10水平低可见于不同遗传病因,不能仅凭此推断特定基因缺陷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the clinical symptoms and biochemical findings and establish the genetic etiology in a cohort of pediatric patients with combined deficiencies of the mitochondrial respiratory chain complexes. STUDY DESIGN: Clinical and biochemical data were collected from 55 children. All patients were subjected to sequence analysis of the entire mitochondrial genome, except when the causative mutations had been identified based on the clinical picture. Whole exome sequencing/whole genome sequencing (WES/WGS) was performed in 32 patients. RESULTS: Onset of disease was generally early in life (median age, 6 weeks). The most common symptoms were muscle weakness, hypotonia, and developmental delay/intellectual disability. Nonneurologic symptoms were frequent. Disease causing mutations were found in 20 different nuclear genes, and 7 patients had mutations in mitochondrial DNA. Causative variants were found in 18 of the 32 patients subjected to WES/WGS. Interestingly, many patients had low levels of coenzyme Q10 in muscle, irrespective of genetic cause. CONCLUSIONS: Children with combined enzyme defects display a diversity of clinical symptoms with varying age of presentation. We established the genetic diagnosis in 35 of the 55 patients (64%). The high diagnostic yield was achieved by the introduction of massive parallel sequencing, which also revealed novel genes and enabled elucidation of new disease mechanisms.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Naess K, Bruhn H, Stranneheim H, et al. Clinical Presentation, Genetic Etiology, and Coenzyme Q10 Levels in 55 Children with Combined Enzyme Deficiencies of the Mitochondrial Respiratory Chain. J Pediatr. 2020. PMID: 32827528. doi:10.1016/j.jpeds.2020.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。